Journal Information
Letter to the Editor
Myositis and myocarditis with tremelimumab and durvalumab combination therapy for hepatocellular carcinoma
Miositis y miocarditis tras terapia combinada de tremelimumab y durvalumab en el carcinoma hepatocelular
Thais Lizondo López
, Iria Carro Méndez, Esther Carcelero San Martín
Corresponding author
Pharmacy Service, Division of Medicines, Hospital Clínic Barcelona, Barcelona, Spain